SUVEN LIFE SCIENCES
Back to All Ratios
|
SUVEN LIFE SCIENCES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | -15.96 | -22.06 | -9.46 | -11.47 | -13.22 |
What is the latest Price to Cash Earnings (PCE) ratio of SUVEN LIFE SCIENCES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | -15.96 |
| Mar2024 | -22.06 |
| Mar2023 | -9.46 |
| Mar2022 | -11.47 |
| Mar2021 | -13.22 |
How is Price to Cash Earnings (PCE) of SUVEN LIFE SCIENCES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | -15.96 | Negative | |
| Mar2024 | -22.06 | Negative | |
| Mar2023 | -9.46 | Negative | |
| Mar2022 | -11.47 | Negative | |
| Mar2021 | -13.22 | - | |
Other Financial Ratios of SUVEN LIFE SCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,624.6 Cr | 1% | -12.2% | 8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 1% |
-12.2% |
8.2% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses